Works matching DE "ARTIFICIAL pancreases"

Results: 715
    1
    2
    3
    4
    5
    6
    7
    8

    Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1582, doi. 10.3390/jcm10081582
    By:
    • de la Rubia Ortí, Jose Enrique;
    • Armero, Jose Luis Platero;
    • Sanchis-Sanchis, Claudia Emmanuela;
    • Sancho-Castillo, Sandra;
    • Salazar, Alejandro;
    • Caplliure-Llopis, Jordi;
    • Navarro-Illana, Esther;
    • Barrios, Carlos;
    • Escribá-Alepuz, Jesús;
    • Benlloch, María
    Publication type:
    Article
    9

    Two Years On.

    Published in:
    Aerospace Medicine & Human Performance, 2021, v. 92, n. 12, p. 927, doi. 10.3357/AMHP.9212PP.2021
    By:
    • DeVoll, James R.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGM.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 4039, doi. 10.1111/dom.16420
    By:
    • Pleus, Stefan;
    • Eichenlaub, Manuel;
    • Eriksson Boija, Elisabet;
    • Diem, Peter;
    • Fokkert, Marion;
    • Hinzmann, Rolf;
    • Jendle, Johan;
    • Klonoff, David C.;
    • Makris, Konstantinos;
    • Nichols, James H.;
    • Pemberton, John;
    • Selvin, Elizabeth;
    • Slingerland, Robbert J.;
    • Thomas, Andreas;
    • Tran, Nam K.;
    • Witthauer, Lilian;
    • Freckmann, Guido
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 688, doi. 10.1111/dom.14911
    By:
    • Igudesman, Daria;
    • Crandell, Jamie;
    • Corbin, Karen D.;
    • Zaharieva, Dessi P.;
    • Addala, Ananta;
    • Thomas, Joan M.;
    • Casu, Anna;
    • Kirkman, M. Sue;
    • Pokaprakarn, Teeranan;
    • Riddell, Michael C.;
    • Burger, Kyle;
    • Pratley, Richard E.;
    • Kosorok, Michael R.;
    • Maahs, David M.;
    • Mayer‐Davis, Elizabeth J.
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Outcomes of hybrid closed‐loop insulin delivery activated 24/7 versus evening and night in free‐living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 511, doi. 10.1111/dom.14605
    By:
    • Renard, Eric;
    • Tubiana‐Rufi, Nadia;
    • Bonnemaison, Elisabeth;
    • Coutant, Régis;
    • Dalla‐Vale, Fabienne;
    • Bismuth, Elise;
    • Faure, Nathalie;
    • Bouhours‐Nouet, Natacha;
    • Farret, Anne;
    • Storey, Caroline;
    • Donzeau, Aurélie;
    • Poidvin, Amélie;
    • Amsellem‐Jager, Jessica;
    • Place, Jérôme;
    • Breton, Marc D.
    Publication type:
    Article
    47
    48
    49

    Alleviating carbohydrate counting with a FiASP‐plus‐pramlintide closed‐loop delivery system (artificial pancreas): Feasibility and pilot studies.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2090, doi. 10.1111/dom.14447
    By:
    • Tsoukas, Michael A.;
    • Cohen, Elisa;
    • Legault, Laurent;
    • von Oettingen, Julia E.;
    • Yale, Jean‐François;
    • Vallis, Michael;
    • Odabassian, Madison;
    • El Fathi, Anas;
    • Rutkowski, Joanna;
    • Jafar, Adnan;
    • Ghanbari, Milad;
    • Gouchie‐Provencher, Nikita;
    • René, Jennifer;
    • Palisaitis, Emilie;
    • Haidar, Ahmad
    Publication type:
    Article
    50

    Reducing the need for carbohydrate counting in type 1 diabetes using closed‐loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non‐inferiority, crossover pilot trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1272, doi. 10.1111/dom.14335
    By:
    • Haidar, Ahmad;
    • Yale, Jean‐Francois;
    • Lovblom, Leif Erik;
    • Cardinez, Nancy;
    • Orszag, Andrej;
    • Falappa, C. Marcelo;
    • Gouchie‐Provencher, Nikita;
    • Tsoukas, Michael A.;
    • El Fathi, Anas;
    • Rene, Jennifer;
    • Eldelekli, Devrim;
    • Lanctôt, Sebastien O.;
    • Scarr, Daniel;
    • Perkins, Bruce A.
    Publication type:
    Article